Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Ischenko

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Oncogene|February 19, 2002
Concomitant activation of the PI3K-Akt and the Ras-ERK signaling pathways is essential for transformation by the V-SEA tyrosine kinase oncogeneYehenew Agazie, Irene Ischenko, Michael Hayman
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreasIrene Ischenko, Oleksi Petrenko, Michael J Hayman
Oncotarget|July 10, 2015
A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cellsIrene Ischenko, Oleksi Petrenko, Michael J Hayman
Oncotarget|February 3, 2017
KRAS-dependent suppression of MYC enhances the sensitivity of cancer cells to cytotoxic agentsIrene Ischenko, Jizu Zhi, Michael J Hayman, et al.
Oncogene|September 26, 2003
Scaffolding protein Gab2 mediates fibroblast transformation by the SEA tyrosine kinaseIrene Ischenko, Oleksi Petrenko, Haihua Gu, et al.
Oncogene|October 10, 2003
The phosphotyrosine phosphatase SHP2 is a critical mediator of transformation induced by the oncogenic fibroblast growth factor receptor 3Yehenew M Agazie, Nieves Movilla, Irene Ischenko, et al.
The Journal of Biological Chemistry|January 6, 2005
The C terminus of RON tyrosine kinase plays an autoinhibitory roleNoriko Yokoyama, Irene Ischenko, Michael J Hayman, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2013
Direct reprogramming by oncogenic Ras and MycIrene Ischenko, Jizu Zhi, Ute M Moll, et al.
Nature Communications|March 6, 2021
KRAS drives immune evasion in a genetic model of pancreatic cancerIrene Ischenko, Stephen D'Amico, Manisha Rao, et al.
Viruses|October 26, 2024
Tsg101 UEV Interaction with Nedd4 HECT Relieves E3 Ligase Auto-Inhibition, Promoting HIV-1 Assembly and CA-SP1 Maturation CleavageSusan M Watanabe, David A Nyenhuis, Mahfuz Khan, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Oncogene|February 19, 2002
Concomitant activation of the PI3K-Akt and the Ras-ERK signaling pathways is essential for transformation by the V-SEA tyrosine kinase oncogeneYehenew Agazie, Irene Ischenko, Michael Hayman
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreasIrene Ischenko, Oleksi Petrenko, Michael J Hayman
Oncotarget|July 10, 2015
A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cellsIrene Ischenko, Oleksi Petrenko, Michael J Hayman
Oncotarget|February 3, 2017
KRAS-dependent suppression of MYC enhances the sensitivity of cancer cells to cytotoxic agentsIrene Ischenko, Jizu Zhi, Michael J Hayman, et al.
Oncogene|September 26, 2003
Scaffolding protein Gab2 mediates fibroblast transformation by the SEA tyrosine kinaseIrene Ischenko, Oleksi Petrenko, Haihua Gu, et al.
Oncogene|October 10, 2003
The phosphotyrosine phosphatase SHP2 is a critical mediator of transformation induced by the oncogenic fibroblast growth factor receptor 3Yehenew M Agazie, Nieves Movilla, Irene Ischenko, et al.
The Journal of Biological Chemistry|January 6, 2005
The C terminus of RON tyrosine kinase plays an autoinhibitory roleNoriko Yokoyama, Irene Ischenko, Michael J Hayman, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2013
Direct reprogramming by oncogenic Ras and MycIrene Ischenko, Jizu Zhi, Ute M Moll, et al.
Nature Communications|March 6, 2021
KRAS drives immune evasion in a genetic model of pancreatic cancerIrene Ischenko, Stephen D'Amico, Manisha Rao, et al.
Viruses|October 26, 2024
Tsg101 UEV Interaction with Nedd4 HECT Relieves E3 Ligase Auto-Inhibition, Promoting HIV-1 Assembly and CA-SP1 Maturation CleavageSusan M Watanabe, David A Nyenhuis, Mahfuz Khan, et al.
Pageof 2